EBOS Group Limited (ASX:EBO – Get Free Report) insider Tracey Batten acquired 2,728 shares of the business’s stock in a transaction that occurred on Thursday, October 30th. The stock was bought at an average cost of A$24.76 per share, for a total transaction of A$67,531.64.
EBOS Group Price Performance
The company has a market cap of $8.20 billion, a PE ratio of 27.51 and a beta of 0.26. The company has a debt-to-equity ratio of 66.89, a current ratio of 0.95 and a quick ratio of 0.76.
EBOS Group Cuts Dividend
The firm also recently declared a Final dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Tuesday, September 23rd were given a dividend of $0.492 per share. The ex-dividend date of this dividend was Wednesday, September 3rd. This represents a yield of 168.0%. EBOS Group’s payout ratio is 72.14%.
About EBOS Group
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services.
Featured Articles
- Five stocks we like better than EBOS Group
- 3 Monster Growth Stocks to Buy Now
- Ford and GM Stocks Jump—Is the Auto Rebound Real?
- Quiet Period Expirations Explained
- Q3 Telecom Wars: How AT&T, TMUS and VZ Stack Up After the Results
- How to Capture the Benefits of Dividend Increases
- Boeing Closes in on Airbus With Best Delivery Quarter Since 2018
Receive News & Ratings for EBOS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EBOS Group and related companies with MarketBeat.com's FREE daily email newsletter.
